
Chordate Medical Holding AB
Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.
CMH | ST
Overview
Corporate Details
- ISIN(s):
- SE0021486131 (+1 more)
- LEI:
- 549300R0GG2J3S0BFN79
- Country:
- Sweden
- Address:
- C/O Regus, 164 40 Kista
- Website:
- https://www.chordate.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Chordate Medical Holding AB is a medical technology company that has developed, patented, and CE-marked Ozilia®, a drug-free neuromodulation treatment technology. The product is designed for the treatment of chronic migraine and chronic rhinitis, offering a clinically proven alternative to conventional medication with minimal side effects. The company markets its treatment in selected markets within the EU and the Middle East. Its business strategy is focused on building value through clinical validation, an extensive patent portfolio, and commercial success stories to attract prospective buyers for a future exit.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Date | Filing | Language | Size | Actions | |
---|---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2021-10-29 | Niklas Lindecrantz | Other | Other | 25,000 | 18,750.00 SEK |
2021-08-23 | Nils Henrik Milton Rammer | Other | Other | 15,000 | 41,100.00 SEK |
2021-08-23 | Nils Henrik Milton Rammer | Other | Other | 15,000 | N/A |
2021-03-04 | Tommy Hedberg | Other | Buy | 75,000 | 40,103.40 SEK |